Abstract Purpose of Review To review current literature on endothelial dysfunction with
previous coronaviruses, and present available data on the role of endothelial dysfunction in …

Objective To perform a scoping review of how patients with COVID-19 are affected by acute
limb ischaemia (ALI) and evaluate the recommendations of the 2020 ESVS ALI Guidelines …

We read with interest the editorial “Anticipating the longterm cardiovascular effects of COVID-
19 [1]” which featured COVID-19 end-organ thrombotic complications. COVID-19 associated …

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

Coronavirus disease 2019 (COVID-19)-associated coagulopathy (CAC), characterized by
hypercoagulability and an increased risk of thrombotic complications, is an important …

Abstract Objective/Background Severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) infection has been associated with thrombotic complications such as deep vein …

Patients with COVID-19 are known to be at risk of developing both venous, arterial and
microvascular thrombosis, due to an excessive immuno-thrombogenic response to the …

Background Recent spread of severe acute respiratory coronavirus syndrome-2 (SARS-CoV-
2) has led to the coronavirus disease (COVID-19) pandemic, resulting in new challenges …

We thank Muzaffar et al.[1] for providing feedback on our study [2]. The aim of our study was
to evaluate the haemostatic profile of mildly ill and severely ill COVID-19 patients. We …

Background There is increasing evidence supporting coronavirus disease 2019 (COVID-19)-
related coagulopathy. In the available literature, only 2 cases of superior mesenteric vein …